Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Plus Therapeutics Inc (PSTV)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Plus Therapeutics's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.710 -0.080    -4.47%
16:00:00 - Closed. Currency in USD ( Disclaimer )
After Hours
1.690
-0.020
-1.170%
16:40:31 - Real-time Data
Type:  Equity
Market:  United States
  • Volume: 6,746
  • Bid/Ask: 1.690 / 1.800
  • Day's Range: 1.687 - 1.790
Plus Therapeutics 1.710 -0.080 -4.47%

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

PSTV Comments

Write your thoughts about Plus Therapeutics Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Chiaretto Calo
Chiaretto Calo Nov 14, 2023 6:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
According to analysts, PSTV stock is rated as a "Strong Buy." The average 12-month stock price forecast is $10.00, representing a substantial increase of over 525% from the current price​​​​​​. Innovative Drug Development: Plus Therapeutics focuses on developing treatments for cancer and other diseases. Their lead drug candidate, Rhenium-186Re obisbemeda, targets central nervous system cancers, including recurrent glioblastoma, leptomeningeal metastases, and pediatric brain cancers. They are also working on other promising treatments for solid organ cancers​​. FDA Orphan Drug Designation: The company recently received U.S. FDA Orphan Drug Designation for Rhenium (186Re) Obisbemeda for the treatment of breast cancer with leptomeningeal metastases. This designation can provide certain benefits, including market exclusivity upon approval, assistance in clinical study design, tax credits, and exemption from FDA user fees​​. Share Repurchase Program: Plus Therapeutics announced a share repurchase program, indicating confidence in their financial stability and future prospects​​. Clinical Trial Progress: The company has been making progress in its clinical trials. For instance, they completed dosing in Cohort 4 of the ReSPECT-LM Phase 1 Clinical Trial of Rhenium (186Re) Obisbemeda in Leptomeningeal Metastases and plan to move into the next cohort following safety reviews​​​​.
Nash Purswani
Nash Purswani Dec 07, 2022 8:58AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Can we file a case against all these analysts who hv giving fake hopes
Péter Dovák
Péter Dovák Aug 18, 2022 6:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
wondering if it hits 2+
Nash Purswani
Nash Purswani Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Zero sales but everyone says strong buy - always confused with this Co but stuck n feels like slow quiksand
Dragan Soldat
Dragan Soldat Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Like others they are expecting discovery of a candidate and then boom It happens but rare
Nash Purswani
Nash Purswani Aug 05, 2021 12:20PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
My thoughts also
Pochette Million
Pochette Million Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its a very strong buy
En Game
En Game Apr 15, 2020 11:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
I guess its an even stronger buy today
victor cruz
victor cruz Nov 14, 2019 4:43PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Its merging from the ashes now.
Scott Wallace
Scott Wallace Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Really what happened????
Sarika Ramonda
Sarika Ramonda Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
$PSTV Plus Therapeutics, Inc. Announces Pricing Of $15 Million Underwritten Public OfferingThe Series U Warrants have an exercise price of $5.00 per share
Jack Wood
Jack Wood Sep 23, 2019 4:05PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stupid firm offered millions of share mid-day at 5$ while stock was still trading at 10$. It just took few seconds to drop to 4$. It was unfair of them to do offering at 5$ as lots of bulls got trapped within seconds.
Roland Jambrich
Roland Jambrich Sep 23, 2019 3:25PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
After 8 yesterday, first 16, then 3,56 today? What's going on here?
ANDREA YACHTSMAN
ANDREA YACHTSMAN Aug 22, 2019 12:54PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
1:50
Nash Purswani
Nash Purswani Aug 16, 2019 11:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
anyone holding the cytori warrants and know how it will be converted - same 50:1 ?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review

Make Smart Decisions.
Research, evaluate, and invest with unique market insights

Volatile markets create opportunities.
Don’t miss out.

Investing Insights
Investing Insights
Investing Insights

Read More

Invest with knowledge

Leverage the wisdom of financial experts and seize market opportunities.

  • Generate investment ideas based on leading Wall Street analyst recommendations.

  • Research trending stocks using 6 unique market factors.

  • Receive market updates in our Insights Newsletter.

Why Investing Insights

5 ways to boost your research

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

  • Objective stock score based on 6 market factors

  • Wall Street analyst price targets and ratings

  • Stock sentiment by bloggers, insiders, and financial gurus

  • News sentiment and score for thousands of stocks

  • Simplified screener with 3 ways to research investment ideas

Stay Ahead. Learn From the Pros.

For the stocks you research, we’ll bring you insights from

Questions & Answers

  • What is Investing Insights?

    Investing Insights is a premium service that provides you with actionable insights from thousands of financial experts that cover the US stock market. Find out which stocks Wall Street analysts, insiders, financial bloggers, hedge fund managers and individual investors are recommending. Investing Insights is available only on our website. Canadian and UK stock markets will soon be added.

  • What is "Smart Score"?

    Smart Score is a powerful scoring system that ranks stocks on a scale of 1-10 based on 6 unique market factors. Smart Score is updated every evening after the market closes, 5 days a week.

  • Can I try Investing Insights for free?

    Yes. You can try Investing Insights for 14 days free of charge.
    The trial period will be followed by a paid subscription. To avoid being charged simply contact our support to cancel the subscription before the trial period ends.
    Please notice that purchases made through PayPal might be subjected to a temporary authorization.

  • How do I cancel my Investing Insights premium subscription?

    In order to cancel your subscription, please contact our support with your registered email or reference number and one of our agents will be happy to assist you.

  • Will I get notified before my subscription renewal?

    Our subscription has automatic renewal, meaning that when you reach the subscription end date, you will be charged automatically and your subscription will be extended. You can cancel your subscription anytime by following the instructions in the answer to the "How do I cancel my Investing Insights subscription" question. The subscription will remain active for the duration of the paid period.

  • What are the available payment methods?

    We accept all major credit cards and debit cards, including Visa, Mastercard, American Express, Discover, JCB, and Diners. Additional payment options may be available in your specific location

Got more questions?

We hope you found the answers you were looking for. You can read more about Insights here. Please go to the Investing Help Center for further information.

By subscribing you agree to TipRanks' Terms and Conditions and Privacy Policy

Powered by
Continue with Google
or
Sign up with Email